Pricing and Reimbursement of Outpatient Drugs

Tuesday, June 12, 2018: 8:00 AM-9:30 AM
1000 - First Floor (Rollins School of Public Health)
Organizer:
W. David Bradford
8:00 AM
Deciphering the code: incentive alignment and biosimilar reimbursement

Author(s): Chris Stomberg; W. David Bradford

Discussant: Stacie Dusetzina
8:20 AM
Coverage and Out-of-Pocket Spending on Brand versus Generic/Biosimilar Specialty Drugs in Medicare Part D

Author(s): Stacie Dusetzina

Discussant: Marta Wosinska
8:40 AM
Increases in Part D Reimbursement for Brand-Name Drugs

Author(s): Stefanie Vance; Emily Dieckman; Edward Burley; Linda Ragone

Discussant: W. David Bradford
See more of: Prescription Drugs
<< Previous Session | Next Session >>

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.